Public-registry site landscape for NCT04886388, a Type 2 Diabetes study sponsored by Better Therapeutics. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04886388 (registry record) |
| Sponsor | Better Therapeutics |
| Condition(s) | Type 2 Diabetes |
| Phase | PHASE3 |
| Listed sites | 6 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT04886388 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →